**Core Concept**
The question is testing the understanding of the side effects of cancer chemotherapy, specifically the ability of anticancer drugs to cause nausea and vomiting. The correct answer requires knowledge of the emetogenic potential of different anticancer agents.

**Why the Correct Answer is Right**
Among the various anticancer drugs, Topotecan is known to have a relatively low emetogenic potential. Topotecan is a topoisomerase I inhibitor that works by stabilizing the cleavage complex of DNA, thereby inhibiting cancer cell growth. Its mechanism of action is less likely to cause nausea and vomiting compared to other anticancer agents like cisplatin, which is a potent emetic.

**Why Each Wrong Option is Incorrect**
**Option A:** Cisplatin is a platinum-based chemotherapeutic agent known to have a high emetogenic potential, making it a wrong choice.
**Option B:** Etoposide is a topoisomerase II inhibitor that can cause significant nausea and vomiting, making it an incorrect option.
**Option C:** Carboplatin is another platinum-based agent with a high emetogenic potential, similar to cisplatin, making it an incorrect choice.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the emetogenic potential of anticancer drugs can vary depending on the dose and schedule of administration. Clinicians often use antiemetic prophylaxis to prevent nausea and vomiting in patients receiving chemotherapy.

**Correct Answer: C. Carboplatin.**